The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.
about
Conceptualizing lennox-gastaut syndrome as a secondary network epilepsyBrain tumorsStable isotope-resolved metabolomics and applications for drug developmentSpatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) depositionDoes visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS studyCoupling between neuronal activity and microcirculation: implications for functional brain imagingBrain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studiesImaging of cerebral blood flow in patients with severe traumatic brain injury in the neurointensive careGlycotherapy: new advances inspire a reemergence of glycans in medicineRadioluminescence microscopy: measuring the heterogeneous uptake of radiotracers in single living cellsBrain imaging of pain: state of the art.An overview of CEST MRI for non-MR physicistsTime to wake up: Studying neurovascular coupling and brain-wide circuit function in the un-anesthetized animalSearching for a baseline: functional imaging and the resting human brainBehind the scenes of functional brain imaging: a historical and physiological perspectiveA computer-assisted image-processing system for the analysis of autoradiographs of cerebral metabolic activityDistinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondriaDifferences in neural activation for object-directed grasping in chimpanzees and humansA thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primatesThe nature of individual differences in inhibited temperament and risk for psychiatric disease: A review and meta-analysis.Diffuse Optics for Tissue Monitoring and Tomography.Advanced neuroimaging in traumatic brain injuryFueling and imaging brain activation.Dysfunction of GABAA receptor glycolysis-dependent modulation in human partial epilepsyWhich linear compartmental systems can be analyzed by spectral analysis of PET output data summed over all compartments?Brain imaging and human nutrition: which measures to use in intervention studies?FDG-PET imaging in mild traumatic brain injury: a critical review.Measurement of regional cerebral glucose uptake by magnetic resonance spin-lock imaging.Interpreting functional imaging studies in terms of neurotransmitter cycling.Evaluation of extra- and intracellular apparent diffusion in normal and globally ischemic rat brain via 19F NMR.Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.Evaluation of 2-[¹⁸F]fluoroacetate kinetics in rodent models of cerebral hypoxia-ischemiaPositron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementiaDominantly inherited Alzheimer's disease: cerebral glucose metabolismPositron emission tomography (PET) in the evaluation of patients with cancer.MR-based molecular imaging of the brain: the next frontier.Synthesis of 5-[18F]Fluoro-α-methyl Tryptophan: New Trp Based PET AgentsDecreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PETNeuroimaging in neuropsychiatric systemic lupus erythematosus.Effects of low-field magnetic stimulation on brain glucose metabolism
P2860
Q21129424-574F5325-9B27-45FD-991F-069CF3C6FF98Q24605136-36F07747-F0E5-48B8-989D-F68192CEC637Q24629149-5840CFF9-6ABD-4D0B-BB90-4A69E1274423Q24631814-10F9EE43-DE53-4E10-94DB-FA1454369293Q24633920-85501BBA-E1B8-4F5B-8CB8-FC7357297DC9Q24650560-739D79DB-BD2B-4A43-A7E3-BA50ADAAC244Q26777636-1F86E746-5459-493E-AE6C-96818DECB5B6Q26852982-1BD942A0-21B5-4885-99E4-D782EB4C9126Q27027997-A78CA44A-38E3-4843-8CE0-052A782A9D55Q27316441-00A770CC-24C8-4B6B-8B61-5B7BDA4A6D20Q28067180-13622D65-9A95-4D8C-80BE-E35710D9E28FQ28072321-A413D035-A9E9-45F9-9550-73E9A808B2E7Q28075288-9DB278E7-066E-479F-BA5E-2EC85BCCB7CDQ28190070-E40DB1F2-3872-45DD-A774-CFB7DEBFE798Q28260353-911AC048-F6BC-46A3-94CA-669EDCAA55F2Q28367476-89DA25BB-BEE6-44CE-9090-4F42D05B75D3Q28534698-ED86C1A5-9061-441F-9C4F-6E5457146D7FQ28681382-68B3A5D9-4390-4358-B380-F671C6018B6CQ30054735-30B2CEEC-CC87-46BD-AFFA-58903BAC4A29Q30387349-B0BCC1FD-6560-436E-96AF-2D84B9C198CAQ30408498-DA82E851-3F83-42D5-BE0E-00B8D227BDEEQ30443904-E349C94E-EA99-4287-BCEE-BB1D6AAD9547Q30465578-6D25CD7B-38B3-45DF-9F5E-217C2B3275A8Q30479036-C60D5753-D3A5-437B-BB6F-BB9365276CB3Q30577238-A25F852A-D1F7-461F-A767-BCE21B1C6C8BQ30658391-0F053A87-B285-4B44-86DD-78A13475863AQ30730474-E27123C6-9B13-419E-B033-A387DB283204Q30833109-BCF750D5-A4DD-4762-B0F3-4728E5321C6DQ32015293-0EA291E3-DD6C-49D9-A42D-D4CFDAE792C9Q32055215-3F5E6B65-7B84-4465-ADA0-8F905C060C24Q33369337-156929A3-F686-49E5-807C-6101894064D9Q33581160-5435DD33-B3F3-4E9C-86AE-BE3D2DA8AB61Q33621605-CCF0E110-C666-4E84-B49F-3796D73B21BEQ33628634-073011AC-1464-45F1-9BCA-DCF4BEE82095Q33645007-33B142E1-70EF-431B-833C-51EE41066863Q33701395-FE1DBCBC-B6CA-409B-97A0-B5F72274EA25Q33703088-750D6670-1044-447E-85DA-5358D09A725DQ33735848-E5A2BB33-771B-43DA-A401-FBB0FCA59DB4Q33753228-FD2F8A03-6DAA-4055-BD9C-B07142370433Q33822052-6B1C7AFE-953C-4240-B883-3C5055709D93
P2860
The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.
description
1979 nî lūn-bûn
@nan
1979 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@ast
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@en
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@nl
type
label
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@ast
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@en
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@nl
prefLabel
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@ast
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@en
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@nl
P2093
P356
P1433
P1476
The [18F]fluorodeoxyglucose me ...... al glucose utilization in man.
@en
P2093
Greenberg J
Sokoloff L
P304
P356
10.1161/01.RES.44.1.127
P577
1979-01-01T00:00:00Z